WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1998029441) HUMAN GALANIN RECEPTOR GALR2 AND NUCLEOTIDES ENCODING SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/1998/029441 International Application No.: PCT/US1997/023892
Publication Date: 09.07.1998 International Filing Date: 18.12.1997
Chapter 2 Demand Filed: 22.07.1998
IPC:
C07K 14/72 (2006.01)
Applicants: SULLIVAN, Kathleen[US/US]; US (UsOnly)
KOLAKOWSKI, Lee, F., Jr.[US/US]; US (UsOnly)
O'DOWD, Brian[CA/CA]; CA (UsOnly)
MERCK & CO., INC.[US/US]; 126 East Lincoln Avenue Rahway, NJ 07065, US (AllExceptUS)
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO[US/US]; Dept. of Pharmacology 7703 Floyd Curl Drive San Antonio, TX 78284, US (AllExceptUS)
UNIVERSITY OF TORONTO[CA/CA]; Dept. of Pharmacology 8 Taddle Creek Road Toronto, Ontario, CA (AllExceptUS)
Inventors: SULLIVAN, Kathleen; US
KOLAKOWSKI, Lee, F., Jr.; US
O'DOWD, Brian; CA
Agent: GIESSER, Joanne, M.; Merck & Co., Inc. 126 East Lincoln Avenue Rahway, NJ 07065, US
Priority Data:
60/033,85127.12.1996US
Title (EN) HUMAN GALANIN RECEPTOR GALR2 AND NUCLEOTIDES ENCODING SAME
(FR) RECEPTEUR DE GALANINE HUMAIN GALR5 ET NUCLEOTIDES QUI LE CODENT
Abstract:
(EN) A new galanin receptor, GALR2, is described. Also provided are nucleic acids encoding same and various assays to identify ligands particular to said receptor. Ligands so identified are useful for the treatment of obesity, treatment of pain, and treatment of cognitive disorders.
(FR) L'invention concerne un nouveau récepteur de galanine, GALR2, ainsi que les acides nucléiques qui le codent. L'invention concerne également divers tests permettant d'identifier les ligands propres à ce récepteur. Les ligands ainsi identifiés sont utiles au traitement de l'obésité, au traitement de la douleur, et au traitement des troubles cognitifs.
Designated States: CA, JP, US
European Patent Office (EPO) (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: English (EN)
Filing Language: English (EN)